Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T20:53:23.403Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:53:23.403Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 3,565,640,813
TTM free cash flow · period ending 2026-06-30: -144,269,000

FMP input reference: 6a4e2115d00bec196f3fe9d6f2351a943ce4894ac8bd63344fcb3f51d437d4a6

P/E Ratio|FCF Growth|Operating Margin|All Metrics

TNGX Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

TNGX Competitors' Price/FCF Ratio

TNGX

Tango Therapeutics, Inc.

Current

Market Cap

$3.57B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VCYT

Veracyte, Inc.

vs TNGX

Market Cap

$3.56B

Price/FCF Ratio

21.53

TTM Avg

27.61

3Y Avg

43.56

5Y Avg

61.80

XENE

Xenon Pharmaceuticals Inc.

vs TNGX

Market Cap

$3.54B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IRTC

iRhythm Technologies, Inc.

vs TNGX

Market Cap

$3.52B

Price/FCF Ratio

90.38

TTM Avg

158.72

3Y Avg

191.31

5Y Avg

191.31

RGC

Regencell Bioscience Holdings Limited

vs TNGX

Market Cap

$3.64B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IDYA

IDEAYA Biosciences, Inc.

vs TNGX

Market Cap

$3.48B

Price/FCF Ratio

N/A

TTM Avg

12.06

3Y Avg

12.04

5Y Avg

12.04

CELC

Celcuity Inc.

vs TNGX

Market Cap

$3.47B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLSE

Pulse Biosciences, Inc.

vs TNGX

Market Cap

$3.44B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACAD

Acadia Pharmaceuticals Inc.

vs TNGX

Market Cap

$3.38B

Price/FCF Ratio

19.38

TTM Avg

26.73

3Y Avg

53.68

5Y Avg

53.68

PBLS

Parabilis Medicines, Inc.

vs TNGX

Market Cap

$3.36B

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Tango Therapeutics, Inc. (TNGX)	$3.57B	N/A	N/A	N/A	N/A
Veracyte, Inc. (VCYT)vs ›	$3.56B	21.53	27.61	43.56	61.80
Xenon Pharmaceuticals Inc. (XENE)vs ›	$3.54B	N/A	N/A	N/A	N/A
iRhythm Technologies, Inc. (IRTC)vs ›	$3.52B	90.38	158.72	191.31	191.31
Regencell Bioscience Holdings Limited (RGC)vs ›	$3.64B	N/A	N/A	N/A	N/A
IDEAYA Biosciences, Inc. (IDYA)vs ›	$3.48B	N/A	12.06	12.04	12.04
Celcuity Inc. (CELC)vs ›	$3.47B	N/A	N/A	N/A	N/A
Pulse Biosciences, Inc. (PLSE)vs ›	$3.44B	N/A	N/A	N/A	N/A
Acadia Pharmaceuticals Inc. (ACAD)vs ›	$3.38B	19.38	26.73	53.68	53.68
Parabilis Medicines, Inc. (PBLS)vs ›	$3.36B	N/A	N/A	N/A	N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

TNGX Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2021-11-09	15.61
2021-11-08	15.55
2021-11-05	15.72
2021-11-04	15.75
2021-11-03	15.94
2021-11-02	15.84
2021-11-01	15.88
2021-10-29	15.79
2021-10-28	15.99
2021-10-27	15.25
2021-10-26	15.87
2021-10-25	15.75
2021-10-22	16.21
2021-10-21	16.02
2021-10-20	15.55
2021-10-19	15.73
2021-10-18	16.11
2021-10-15	17.26
2021-10-14	17.58
2021-10-13	17.12
2021-10-12	16.98
2021-10-11	16.63
2021-10-08	17.36
2021-10-07	16.82
2021-10-06	16.98
2021-10-05	17.16
2021-10-04	16.54
2021-10-01	16.18
2021-09-30	15.91
2021-09-29	14.80
2021-09-28	15.56
2021-09-27	16.31
2021-09-24	16.68
2021-09-23	18.19
2021-09-22	19.44
2021-09-21	18.37
2021-09-20	20.42
2021-09-17	21.28
2021-09-16	20.90
2021-09-15	19.47
2021-09-14	19.14
2021-09-13	19.40
2021-09-10	19.18
2021-09-09	19.29
2021-09-08	18.54
2021-09-07	18.27
2021-09-03	15.91
2021-09-02	14.76
2021-09-01	14.77
2021-08-31	14.32
2021-08-30	14.66
2021-08-27	15.62
2021-08-26	15.30
2021-08-25	15.56
2021-08-24	15.65
2021-08-23	15.61
2021-08-20	13.67
2021-08-19	12.25
2021-08-18	12.28
2021-08-17	12.09
2021-08-16	11.77
2021-08-13	12.14
2021-08-12	11.76
2021-08-11	12.29
2021-08-10	12.55
2021-08-09	12.55
2021-08-06	13.11
2021-08-05	12.92
2021-08-04	12.83
2021-08-03	12.96
2021-08-02	12.99
2021-07-30	13.01
2021-07-29	13.12
2021-07-28	12.92
2021-07-27	12.91
2021-07-26	13.11
2021-07-23	13.65
2021-07-22	13.95
2021-07-21	13.60
2021-07-20	13.64
2021-07-19	13.99
2021-07-16	13.94
2021-07-15	13.94
2021-07-14	14.09
2021-07-13	14.16
2021-07-12	14.29
2021-07-09	14.18
2021-07-08	14.42
2021-07-07	14.57
2021-07-06	14.72
2021-07-02	14.30
2021-07-01	14.56
2021-06-30	14.78
2021-06-29	14.30
2021-06-28	14.53
2021-06-25	14.30
2021-06-24	14.81
2021-06-23	14.33
2021-06-22	14.33
2021-06-21	14.51
2021-06-18	14.44
2021-06-17	14.90
2021-06-16	14.57
2021-06-15	14.81
2021-06-14	14.22
2021-06-11	14.29
2021-06-10	14.33
2021-06-09	14.33
2021-06-08	14.29
2021-06-07	14.16
2021-06-04	14.22
2021-06-03	14.26
2021-06-02	14.29
2021-06-01	14.33
2021-05-28	14.55
2021-05-27	14.22
2021-05-26	14.51
2021-05-25	14.53
2021-05-24	14.29
2021-05-21	14.31
2021-05-20	13.89
2021-05-19	13.77
2021-05-18	13.64
2021-05-17	14.00
2021-05-14	14.56
2021-05-13	14.33
2021-05-12	13.71
2021-05-11	14.47
2021-05-10	14.90
2021-05-07	13.71
2021-05-06	14.59
2021-05-05	14.64
2021-05-04	14.97
2021-05-03	14.97
2021-04-30	14.83
2021-04-29	14.61
2021-04-28	14.62
2021-04-27	14.38
2021-04-26	14.17
2021-04-23	14.46
2021-04-22	13.95
2021-04-21	14.33
2021-04-20	13.96
2021-04-19	13.85
2021-04-16	15.73
2021-04-15	16.29
2021-04-14	15.35
2021-04-13	14.22
2021-04-12	13.96
2021-04-09	14.27
2021-04-08	14.40
2021-04-07	14.33
2021-04-06	14.46
2021-04-05	13.94
2021-04-01	13.93

Price/FCF Ratio: N/A

TNGX Price/FCF Ratio Chart

TNGX Price/FCF Ratio Metrics

TNGX Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

TNGX Price/FCF Ratio History

Related Metrics